wet AMD RPED RPED Retinal Pigment Epithelial Detachment AMD Age-
Conditions
Interventions
VEGF administered to the patients is routine treatment care as well as OCT scanning from SPECTRALIS SD-
OCT after treatment in each visit., The patients with RPED secondary to wet AMD who have been treated with anti-
OCT after treatment in each visit.
Treatment,Treatment,Treatment
The patients with RPED secondary to wet AMD who have been treated with anti-
VEGF at King Chulalongkorn Memorial Hospital from Jan 2010 to Jan 2017 who is eligible to inclusion criteria will be enrolled to the study. Intravitreal anti-
The patients with RPED secondary to wet AMD treated with intravitreal Bevacizumab,The patients with RPED secondary to wet AMD treated with intravitreal Ranibizumab,The patients with RPED secondary
Sponsors
Faculty of Medicine, Chulalongkorn University
N/A,N/A
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Newly diagnosed wet AMD patient confirmed by FFA or OCT and diagnosed by retina specialist in 2010 to 2017 2. Presence of PED at the time of diagnosis 3. No history of previous macular laser treatment or photodynamic therapy 4. No concurrent other macular diseases in the study eye Obtained OCT scanning from SPECTRALIS SD-OCT
Exclusion criteria
Exclusion criteria: 1. Poor quality of OCT image at baseline and at 12th month visit 2. Lost follow up before 6th month visit 3. Presence of RPE rip after initial Anti VEGF treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Height and area of Pigment epithelial detachment 6 months Optical coherence tomography | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual acuity 6 months ETDRS chart,Sub retinal fluid 6 months Optical coherence tomography,Central foveal thickness 6months Optical coherence tomography,Number of injections and visits 6months From chart review | — |
Contacts
Public ContactPear Pongsachareonnont
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed